EMT is characterized by the down-regulation of E-cadherin, an epithelial marker; the up-regulation of mesenchymal markers, such as Vimentin, N-cadherin, and Snail; and the potently enhanced ability of tumor cell invasion and metastasis [10–13]. The gene discussed is CDH1; the disease is neoplasm.